Last updated on September 2008

Cardiovascular Phenotype Study in Patients With Obstructive Sleep Apnea Syndrome


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Hypertension | Obstructive Sleep Apnea Syndrome
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other:
    patients with or without obstructive sleep apnea syndrome (AHI > 15)
    patients with or without hypertension

You may not be eligible for this study if the following are true:

  • known or expected secondary hypertension
    pathologies with consequences on arterial blood pressure regulation: Parkinson's
    disease, patients with renal or cardiac graft, severe heart failure
    drugs with consequences on arterial blood pressure regulation : vasoconstrictors,
    vasodilatators, béta-agonists, antagonists, nitrites, theophylline, dipyridamol,
    ildenafil, immunosuppressors, IMAO, neuroleptics, tricyclic antidepressants,
    corticoids or long-term oral (>10 days) non steroidal anti-inflammatory drugs,
    oestroprogestative treatments
    atrial fibrillation, frequent extrasystoles (> or = to 10/minute)
    bedridden patients
    night shift workers
    surgical or carotid stenting history
    subjects unwilling or unable to provide written, signed and dated informed consent
    patient previously treated for obstructive sleep apnea syndrome (positive airway
    pressure, forward mandible prosthesis, maxillofacial surgery

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.